| Financial Year |
March 31 2023 |
| Monetary Funds |
381,563,047.99 |
| Held-for-trading Financial Assets |
1,061,610,516.36 |
| Notes Receivable |
5,557,366.49 |
| Accounts Receivable |
137,728,423.58 |
| Advances to Suppliers |
14,291,044.40 |
| Other Receivables |
15,652,878.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
234,477,805.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,946,583.32 |
| Total Current Assets |
1,872,788,790.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,050,444.57 |
| Long-term Equity Investment |
404,065,798.96 |
| Investment Properties |
164,589,271.88 |
| Fixed Assetes |
1,448,264,814.27 |
| Under-construction Projects |
5,574,259.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
204,540,898.35 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
17,327,220.64 |
| Deferred Income Tax Assets |
73,040,109.49 |
| Other Non-Current Assets |
3,941,544.85 |
| Sub-Total of Non-Current Assets |
2,449,821,216.69 |
| Total Assets |
4,322,610,006.86 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
151,006,945.26 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,289,318.69 |
| Taxes Payable |
44,441,470.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
56,536,245.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,657,878.79 |
| Other Current Liabilities |
25,764,332.54 |
| Sub-Total of Current Liabilities |
462,160,545.49 |
| Long-term Loans |
-- |
| Bonds Payable |
593,757,133.46 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
51,494,590.92 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
804,968,530.20 |
| Total Liabilities |
1,267,129,075.69 |
| Paid-In Capital(Or Share Stock) |
311,283,362.00 |
| Capital Surplus |
814,398,813.72 |
| Surplus Reserve |
163,702,670.55 |
| LESS:Treasury Stock |
164,125,862.91 |
| Undistributed Profits |
1,892,313,870.50 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,055,480,931.17 |
| Owner's Equity（Stockholder's Equity） |
3,055,480,931.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,322,610,006.86 |
